Cardiovascular Critical Care II
iii.
Emergent coronary angiography is no longer recommended over a delayed/selective
strategy in patients with ROSC after cardiac arrest. Exceptions exist for patients
with ST-segmentβelevation myocardial infarction, shock, electrical instability, signs
of significant myocardial damage, or ongoing ischemia (Circulation 2024;149:e254-
73). An analysis suggests that risk stratification and admission prognosis can
help determine which patients will benefit from angiography (JACC Cardiovasc Interv
2018;11:249-56).
iv.
Effects of antiplatelet and antithrombotic drugs augmented by derangements in normal platelet
activation/coagulation pathways caused by hypothermia.
See the Cardiology chapter for the workup and treatment of acute coronary syndromes.
Optimize mechanical ventilation.
Goal arterial oxygen saturation is 94% or greater. A recent study found equivocal results
with restrictive (Pao2 target of 68β75 mm Hg) versus liberal (Pao2 target of 98β105 mm Hg)
oxygenation targets in comatose survivors of OHCA (N Engl J Med 2022;387:1456-66).
ii.
Avoid hyperventilation or over-bagging to avoid increase in intrathoracic pressure and decrease
in cardiac output.
iii.
Goal Paco2 is 40β45 mm Hg or Petco2 35β40 mm Hg.
| d. | Support organ systems |
|---|
Vasopressor/inotropes to support end-organ perfusion (see Table 6)
| (a) | Adrenergic medications should not be administered with alkaline solutions or sodium |
|---|
bicarbonate because they are inactivated (Hosp Pharm 1969;4:14-22).
| (b) | Central line is recommended because any agent with Ξ±-agonist properties can lead to |
|---|
extravasation and tissue necrosis.
Medication
Typical Dosing
Range
(mcg/kg/min)
Clinical Pearls
Epinephrine
0.03β0.3
Mixed Ξ± and Ξ² (1 > 2) activity
Used to treat severe hypotension (e.g., SBP < 70 mm Hg)
Used for symptomatic bradycardia
Used for hemodynamically unstable anaphylactic reactions
Higher doses associated with increased Ξ±1 activity
Norepinephrine
0.03β0.3
Ξ± > Ξ² (1 > 2) receptor activity
Used to treat severe hypotension (e.g., SBP < 70 mm Hg)
Should be used in volume-resuscitated patients
First line for septic shock
Higher doses associated with increased Ξ±1 activity
Phenylephrine
0.3β3
Pure Ξ±-agonist
Used to treat severe hypotension (e.g., SBP < 70 mm Hg)
Should be used in volume-resuscitated patients
Avoid in patients with low cardiac output